Literature DB >> 33484447

Functional miR143/145 Cluster Variants and Haplotypes Are Associated with Chronic Kidney Disease: a Preliminary Case-Control Study and Computational Analyses.

Saman Sargazi1, Milad Heidari Nia2, Fariba Mirani Sargazi2, Roghayeh Sheervalilou2, Ramin Saravani3,4, Sara Bahrami2, Shekoufeh Mirinejad2, Ali Alidadi5.   

Abstract

MiR-143/145 cluster is a novel transcriptional target of many signaling pathways, with variations within this cluster contributed to the risk of multiple diseases. To date, no data regarding the link between miR143/145 cluster polymorphisms and the risk of developing chronic kidney disease (CKD) has been reported. Hence, we aimed to examine such association in a population of Iranian ancestry. In this preliminary study, 276 CKD patients and 300 unrelated age and sex-matched healthy controls were recruited. Genotyping was performed by PCR-RFLP and allele-specific-PCR methods. Computational analyses were performed to predict the potential effects of the variants. Our findings indicated that rs41291957, rs12659504, and rs353292 polymorphisms were positively associated with CKD, while rs4705342 and rs4705343 polymorphisms demonstrated a significant negative association with the disease. Moreover, a significant association was observed between CC + TC and TT genotypes and CKD stages. We found that AACTT, AATTC, AATTT, GATTC, GATTT, and GGCTT haplotypes significantly enhanced the risk of CKD compared with the Grs41291957AArs12659504Crs353292Trs4705342Trs4705343 haplotype. Computational analysis showed that rs353292, rs4705342, and rs4705343 might alter the binding of the transcription factors in this gene cluster. We found that miR-143/145 cluster polymorphisms were associated with CKD risk in a sample of the Iranian population. Replicated studies on different ethnicities are necessary to investigate the association between these promoter variants and clinical outcomes.

Entities:  

Keywords:  Bioinformatics analysis; Chronic kidney disease; Haplotype; MicroRNAs

Mesh:

Substances:

Year:  2021        PMID: 33484447     DOI: 10.1007/s12010-021-03489-w

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   2.926


  42 in total

Review 1.  Oral and dental aspects of chronic renal failure.

Authors:  R Proctor; N Kumar; A Stein; D Moles; S Porter
Journal:  J Dent Res       Date:  2005-03       Impact factor: 6.116

2.  Racial and ethnic differences in kidney function decline among persons without chronic kidney disease.

Authors:  Carmen A Peralta; Ronit Katz; Ian DeBoer; Joachim Ix; Mark Sarnak; Holly Kramer; David Siscovick; Steven Shea; Moyses Szklo; Michael Shlipak
Journal:  J Am Soc Nephrol       Date:  2011-06-23       Impact factor: 10.121

Review 3.  Progression in chronic kidney disease.

Authors:  Allison A Eddy
Journal:  Adv Chronic Kidney Dis       Date:  2005-10       Impact factor: 3.620

4.  Association of glutathione S-transferase M1 and T1 gene polymorphism with oxidative stress in diabetic and nondiabetic chronic kidney disease.

Authors:  Sudip K Datta; Vivek Kumar; Rahul Pathak; Ashok K Tripathi; Rafat S Ahmed; Om P Kalra; Basu D Banerjee
Journal:  Ren Fail       Date:  2010       Impact factor: 2.606

5.  Phagocytic polymorphonuclear function in patients with progressive uremia and the effect of acute hemodialysis.

Authors:  Sandeep Mahajan; Om P Kalra; K Tripathi Asit; Gaurav Ahuja; Vikram Kalra
Journal:  Ren Fail       Date:  2005       Impact factor: 2.606

6.  Association of a polymorphism of the apolipoprotein E gene with chronic kidney disease in Japanese individuals with metabolic syndrome.

Authors:  Tetsuro Yoshida; Kimihiko Kato; Tetsuo Fujimaki; Kiyoshi Yokoi; Mitsutoshi Oguri; Sachiro Watanabe; Norifumi Metoki; Hidemi Yoshida; Kei Satoh; Yukitoshi Aoyagi; Yutaka Nishigaki; Masashi Tanaka; Yoshinori Nozawa; Yoshiji Yamada
Journal:  Genomics       Date:  2008-12-06       Impact factor: 5.736

7.  National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification.

Authors:  Ronald J Hogg; Susan Furth; Kevin V Lemley; Ronald Portman; George J Schwartz; Josef Coresh; Ethan Balk; Joseph Lau; Adeera Levin; Annamaria T Kausz; Garabed Eknoyan; Andrew S Levey
Journal:  Pediatrics       Date:  2003-06       Impact factor: 7.124

Review 8.  Circulating miRNAs: roles in cancer diagnosis, prognosis and therapy.

Authors:  Guofeng Cheng
Journal:  Adv Drug Deliv Rev       Date:  2014-09-16       Impact factor: 15.470

9.  What do we know about chronic kidney disease in India: first report of the Indian CKD registry.

Authors:  Mohan M Rajapurkar; George T John; Ashok L Kirpalani; Georgi Abraham; Sanjay K Agarwal; Alan F Almeida; Sishir Gang; Amit Gupta; Gopesh Modi; Dilip Pahari; Ramdas Pisharody; Jai Prakash; Anuradha Raman; Devinder S Rana; Raj K Sharma; R N Sahoo; Vinay Sakhuja; Ravi Raju Tatapudi; Vivekanand Jha
Journal:  BMC Nephrol       Date:  2012-03-06       Impact factor: 2.388

Review 10.  Genetic polymorphisms of the RAS-cytokine pathway and chronic kidney disease.

Authors:  Craig Wong; Peter Kanetsky; Dominic Raj
Journal:  Pediatr Nephrol       Date:  2008-05-15       Impact factor: 3.714

View more
  1 in total

1.  A functional polymorphism of microRNA-143 is associated with the risk of type 2 diabetes mellitus in the northern Chinese Han population.

Authors:  Dexian Kong; Ya Duan; Jinli Wang; Yabin Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-23       Impact factor: 6.055

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.